SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-022271
Filing Date
2023-06-15
Accepted
2023-06-15 16:45:43
Documents
13
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20230615.htm   iXBRL 8-K 67249
5 crdf-20230615_g1.jpg GRAPHIC 2732
  Complete submission text file 0001628280-23-022271.txt   206785

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230615.xsd EX-101.SCH 1925
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230615_lab.xml EX-101.LAB 22877
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230615_pre.xml EX-101.PRE 12001
7 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230615_htm.xml XML 10063
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 231018040
SIC: 2836 Biological Products, (No Diagnostic Substances)